Replies to post #9361 on Algernon Pharmaceuticals Inc (AGNPF)

[shell3]

It shouldn’t “is the glass half full or half empty”

My thinking is this about like this

24,401,300 Warrants have the 6 Month Rule added to it on the November PP

Of those 24,401,300 Warrants 17,637,083 have already Exercised (JMO)

Filed May 5th Report
Quote:
5,446,660
Issued 5,446,660 common shares as a result of 5,446,660 warrants with an exercise price of $0.12 being exercised for proceeds of $653,599.20

Filed April 5th Report
Quote:
12,190,423
Issued 12,190,423 common shares as a result of 12,190,423 warrants with an exercise price of $0.12 being exercised for proceeds of $1,462,850.76

This new Filing smoki Just Posted — Another 360,000 plus must have Exercised as Outstanding grew 360,000 plus from Apri 27th threw May 2nd

So roughly 6M left to Exercise of that 24,401,300 Warrants on November PP

So roughly $511,200 USD or $AGNPF value left on November PP to Exercise

The February PP was waived to never being able to make them buy but is the same price of .12 AGN and 18M plus have on November PP so they’ll probably also Exercise on or around their June 21st date being able to sell as those that did on the November PP which was March 3rd they could sell

Needing Cash fast and only Warrants able to impact the acceleration and coming from the same Friends and Family with an addition to a USA buyer this time and they gather $6.86M CAD within a week or $4,870,600 USD Value

Roughly altogether is 24M Warrants left @ .12 AGN or .0852 $AGNPF
1,505,293 Agent Warrants May PP @ .35 AGN or 0.2485 $AGNPF
19,605,285 Warrants May PP @ .55 AGN or .0.3905 $AGNPF

Hope that helps some